Table 1.
UNAIDS progress metrics by GBD super-region in 2010 and 2019
| IMR, 2010 | IMR, 2019 | IPR, 2010 | IPR, 2019 | Percentage change in deaths, 2010–19 | Percentage change in incidence, 2010–19 | |
|---|---|---|---|---|---|---|
| Global | 1·59 (1·53 to 1·65) | 1·94 (1·76 to 2·12) | 0·08 (0·07 to 0·09) | 0·05 (0·05 to 0·06) | −36·75% (−39·95 to −32·64) | −16·10% (−22·31 to −8·07) |
| Central Europe, eastern Europe, and central Asia | 2·82 (2·41 to 3·29) | 4·76 (3·96 to 5·78) | 0·15 (0·12 to 0·19) | 0·11 (0·09 to 0·12) | 6·85% (5·10 to 8·57) | 107·45% (72·66 to 139·13) |
| High income | 3·29 (2·45 to 4·17) | 3·91 (2·65 to 4·98) | 0·04 (0·03 to 0·05) | 0·04 (0·03 to 0·05) | −20·26% (−21·02 to −19·55) | 35·65% (3·38 to 55·91) |
| Latin America and Caribbean | 2·25 (2·07 to 2·49) | 2·61 (2·31 to 3·04) | 0·09 (0·08 to 0·11) | 0·07 (0·06 to 0·08) | −12·61% (−18·36 to −6·92) | 11·75% (−1·82 to 23·47) |
| North Africa and Middle East | 1·97 (1·27 to 3·18) | 2·37 (1·48 to 4·19) | 0·13 (0·10 to 0·17) | 0·12 (0·08 to 0·17) | 24·06% (−14·03 to 81·80) | 52·40% (−2·87 to 172·14) |
| South Asia | 0·73 (0·54 to 0·95) | 1·40 (0·90 to 1·94) | 0·06 (0·04 to 0·08) | 0·05 (0·03 to 0·07) | −60·25% (−66·18 to −44·03) | −13·77% (−40·18 to 33·70) |
| Southeast Asia, east Asia, and Oceania | 1·87 (1·62 to 2·23) | 1·83 (1·6 to 2·19) | 0·08 (0·07 to 0·01) | 0·07 (0·06 to 0·08) | 5·96% (−8·69 to 18·17) | 4·91% (−7·40 to 16·76) |
| Sub-Saharan Africa | 1·51 (1·46 to 1·57) | 1·63 (1·44 to 1·82) | 0·08 (0·07 to 0·01) | 0·05 (0·04 to 0·06) | −39·73% (−42·36 to −36·49) | −28·50% (−35·43 to −19·58) |
Data in parentheses are 95% uncertainty intervals. The IPR threshold was set as less than 0·03, and the threshold for the IMR was set to less than 1·0. The incidence and deaths threshold was at least a 75% reduction since 2010.8 GBD=Global Burden of Diseases, Injuries, and Risk Factors Study. IMR=incidence-to-mortality ratio. IPR=incidence-to-prevalence ratio.